Protein
Protein (NP_001137)
Angiopoietin-1
Angiopoietin-1 (ANG-1)
ANGPT1
angiopoietin 1
Undefined
Very low evidence
Ficolin-like
Undefined
a/b mixed with b-sheet / Fibrinogen C-ter like
MTVFLSFAFLAAILTHIGCSNQRRSPENSGRRYNRIQHGQCAYTFILPEHDGNCRESTTDQYNTNALQRDAPHVEPDFSSQKLQHLEHVMENYTQWLQKLENYIVENMKSEMAQIQQNAVQNHTATMLEIGTSLLSQTAEQTRKLTDVETQVLNQTSRLEIQLLENSLSTYKLEKQLLQQTNEILKIHEKNSLLEHKILEMEGKHKEELDTLKEEKENLQGLVTRQTYIIQELEKQLNRATTNNSVLQKQQLELMDTVHNLVNLCTKEGVLLKGGKREEEKPFRDCADVYQAGFNKSGIYTIYINNMPEPKKVFCNMDVNGGGWTVIQHREDGSLDFQRGWKEYKMGFGNPSGEYWLGNEFIFAITSQRQYMLRIELMDWEGNRAYSQYDRFHIGNEKQNYRLYLKGHTGTAGKQSSLILHGADFSTKDADNDNCMCKCALMLTGGWWFDACGPSNLNGMFYTAGQNHGKLNGIKWHYFKGPSYSLRSTTMMIRPLDF
Mol* PDB structure viewerUniLectin3D
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (3 PubMed Identifiers)
- Rethinking isolated cleft lip and palate as a syndrome. [29500156]
- The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. [12975309]
- Cloning and characterization of Igsf9 in mouse and human: a new member of the immunoglobulin superfamily expressed in the developing nervous system. [11991715]
UniProt Main References (15 PubMed Identifiers)
- Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. [8980223]
- Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. [7584026]
- The full-ORF clone resource of the German cDNA Consortium. [17974005]
- DNA sequence and analysis of human chromosome 8. [16421571]
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
- Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones. [12168954]
- Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. [9204896]
- Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. [12427764]
- Biological characterization of angiopoietin-3 and angiopoietin-4. [15284220]
- Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. [18425120] Show more
All isoforms of this gene containing a lectin domain
RNA
RNA (Transcript ID: NM_001135050.2)
immunoglobulin superfamily member 9, transcript variant 1
m7G-5')ppp(5'-AUUGUGUAGCGGCGAGAGUGGAGCCGAGCGGUGCGGAGCAGAUCUGGUGGUUCUCCGGAGAGCAGCUUCCUCGGGUGUUACAUGAGCCAAGCCCUCACUGUACAGAAGAGUGAGAGCUGAAACCUGUUCCCUGAGCUGAUCAGAAGGACAUCCCUUGGCCCCUCCAUCUGGGCUCCUGUGGAUAGGAGGGGCUGGGUGAGCAGGCCAGCUGGGCUAUGGUGUGGUGCCUCGGCCUGGCCGUCCUCAGCCUGGUCAUCAGCCAGGGGGCUGACGGUCGAGGGAAGCCUGAGGUGGUAUCGGUGGUGGGCCGGGCUGGGGAGAGUGUGGUGCUGGGCUGUGACCUGCUGCCCCCGGCCGGCCGGCCCCCCCUGCAUGUCAUCGAGUGGCUGCGCUUUGGAUUCCUGCUUCCCAUCUUCAUCCAGUUCGGCCUCUACUCUCCCCGAAUUGACCCUGAUUACGUGGGACGAGUCCGGCUGCAGAAGGGGGCCUCUCUCCAGAUUGAGGGUCUCCGGGUGGAAGACCAGGGCUGGUACGAGUGCCGCGUGUUCUUCCUGGACCAGCACAUCCCUGAAGACGAUUUUGCUAACGGCUCCUGGGUGCAUCUGACAGUCAAUUCACCCCCUCAAUUCCAGGAGACACCUCCUGCUGUGUUGGAAGUGCAGGAACUGGAGCCUGUGACCCUGCGUUGUGUGGCCCGUGGCAGCCCCCUGCCUCAUGUGACGUGGAAGCUCCGAGGAAAGGACCUUGGCCAGGGCCAGGGCCAGGUGCAAGUGCAGAACGGGACGCUGCGGAUCCGCCGGGUAGAGCGAGGCAGCUCUGGGGUCUACACCUGCCAAGCCUCCAGCACUGAGGGCAGCGCCACCCACGCCACCCAGCUGCUAGUGCUAGGACCCCCAGUCAUCGUGGUGCCCCCCAAGAACAGCACAGUCAAUGCCUCCCAGGAUGUUUCAUUGGCCUGCCAUGCUGAGGCAUACCCUGCUAACCUCACCUACAGCUGGUUCCAGGACAACAUCAAUGUCUUCCACAUUAGCCGCCUGCAGCCCCGGGUGCGGAUCCUGGUGGACGGGAGCCUGCGGCUGCUGGCCACCCAGCCUGAUGAUGCCGGCUGCUACACCUGUGUGCCCAGCAAUGGCCUCCUGCAUCCACCCUCAGCCUCUGCCUACCUCACUGUGCUCUACCCAGCCCAGGUGACAGCUAUGCCUCCUGAGACACCCCUGCCCAUAGGCAUGCCGGGGGUGAUCCGCUGCCCGGUUCGUGCCAACCCCCCACUGCUCUUUGUCAGCUGGACCAAGGAUGGAAAGGCCCUGCAGCUGGACAAGUUCCCUGGCUGGUCCCAGGGCACAGAAGGCUCACUGAUCAUCGCCCUGGGGAACGAGGAUGCCCUGGGAGAAUACUCCUGCACCCCCUACAACAGUCUUGGUACCGCCGGGCCCUCUCCUGUGACCCGCGUGCUGCUCAAGGCUCCCCCAGCUUUUAUAGAGCGGCCCAAGGAAGAAUAUUUCCAAGAAGUAGGGCGGGAGCUGCUCAUCCCCUGCUCCGCCCAAGGGGACCCUCCUCCUGUUGUCUCUUGGACCAAGGUGGGCCGGGGGCUGCAAGGCCAGGCCCAGGUGGACAGCAACAGCAGCCUCAUCCUGCGACCAUUGACCAAGGAGGCCCACGGGCACUGGGAAUGCAGUGCCAGCAAUGCUGUGGCCCGAGUGGCCACCUCCACGAACGUCUACGUGCUGGGCACUAGCCCUCAUGUUGUCACCAAUGUGUCCGUGGUGGCUUUGCCCAAGGGUGCCAAUGUCUCCUGGGAGCCUGGCUUUGAUGGUGGUUAUCUGCAGAGAUUCAGUGUCUGGUACACCCCACUGGCCAAGCGUCCUGACCGAAUGCACCAUGACUGGGUGUCCUUGGCAGUGCCUGUGGGGGCUGCUCACCUCCUAGUGCCAGGGCUGCAGCCCCACACCCAGUACCAGUUCAGCGUGCUAGCUCAGAACAAGCUGGGGAGUGGUCCCUUCAGCGAAAUCGUCUUGUCUGCUCCGGAAGGGCUUCCUACCACGCCAGCUGCACCCGGGCUUCCCCCAACAGAGAUACCGCCUCCCCUGUCCCCUCCGCGGGGUCUGGUGGCAGUGAGGACACCCCGGGGGGUACUCCUGCAUUGGGAUCCCCCAGAGCUGGUCCCUAAGAGACUGGAUGGCUACGUCUUGGAAGGCCGGCAAGGCUCCCAGGGCUGGGAGGUGCUGGACCCGGCUGUGGCAGGCACAGAAACAGAGCUGCUGGUGCCAGGCCUCAUCAAGGAUGUUCUCUACGAGUUCCGCCUCGUGGCCUUCGCGGGCAGCUUCGUCAGCGACCCCAGCAACACGGCCAACGUCUCCACUUCCGGUCUGGAGGUCUACCCUUCGCGCACGCAGCUGCCGGGCCUCCUGCCUCAGCCCGUGCUGGCCGGCGUGGUGGGCGGAGUCUGCUUUCUGGGAGUGGCCGUCCUUGUGAGCAUCCUGGCCGGCUGCCUCCUGAACCGGCGCAGGGCUGCCCGCCGCCGCCGCAAGCGCCUCCGCCAAGAUCCACCUCUUAUCUUCUCUCCGACCGGGAAGUCAGCUGCACCCUCUGCUCUGGGCUCAGGCAGUCCUGACAGCGUGGCGAAGCUGAAGCUCCAGGGAUCCCCAGUCCCCAGCCUGCGCCAGAGUCUGCUCUGGGGGGAUCCUGCCGGAACUCCCAGCCCCCACCCGGAUCCUCCAUCUAGCCGGGGACCCUUACCUCUGGAGCCCAUUUGCCGGGGCCCAGACGGGCGCUUUGUGAUGGGGCCCACUGUGGCGGCCCCCCAGGAAAGGUCAGGCCGGGAGCAGGCAGAACCUCGGACUCCAGCCCAGCGUCUGGCCCGGUCCUUUGACUGUAGCAGCAGCAGCCCCAGUGGGGCACCCCAGCCCCUCUGCAUUGAAGACAUCAGCCCUGUGGCACCCCCUCCAGCAGCCCCACCCAGUCCCUUGCCAGGUCCUGGACCCCUGCUCCAGUACCUGAGCCUGCCCUUCUUCCGAGAGAUGAAUGUGGAUGGGGACUGGCCCCCGCUUGAGGAGCCCAGCCCUGCUGCACCCCCAGAUUACAUGGAUACCCGGCGCUGUCCCACCUCAUCUUUCCUUCGUUCUCCAGAAACCCCUCCUGUAUCCCCCAGGGAAUCACUUCCUGGGGCUGUGGUAGGGGCUGGGGCCACUGCAGAGCCCCCUUACACAGCCCUGGCUGACUGGACACUGAGGGAGCGGCUGCUGCCAGGCCUUCUCCCUGCUGCCCCUCGAGGCAGCCUCACCAGCCAGAGCAGUGGGCGAGGCAGCGCUUCGUUCCUGCGGCCCCCCUCCACAGCCCCCUCUGCAGGAGGCAGCUACCUCAGCCCUGCUCCAGGAGACACCAGCAGCUGGGCCAGUGGCCCUGAGAGAUGGCCCCGAAGGGAGCAUGUGGUGACAGUCAGCAAGAGGAGGAACACAUCUGUGGACGAGAACUAUGAGUGGGACUCAGAAUUCCCUGGGGACAUGGAAUUGCUGGAGACUUUGCACCUGGGCUUGGCCAGCUCCCGGCUCAGACCUGAAGCUGAGCCAGAGCUAGGUGUGAAGACUCCAGAGGAGGGCUGCCUCCUGAACACUGCCCAUGUUACUGGCCCUGAGGCCCGCUGUGCUGCCCUUCGGGAGGAAUUCCUGGCCUUCCGCCGCCGCCGAGAUGCUACUAGGGCUCGGCUACCAGCCUAUCGACAGCCAGUCCCCCACCCCGAACAGGCCACUCUGCUGUGAACAUCCCUGAUGUGAGGCUGUGAAAAGGCAUAUGGACCUGCAAAGGAGGCCCCCAACCAGACAGACCUAGUUUCAAACGAGGGCACUGCCCCUGCCUGCCCCUUUGGUGCCCAGGCACAGACCCUGAUAGUGGGUUUGGGUCACCUUGGUAUGGAAUGUAUGUGCUGACCCCCUAGGUGAGUCUGGGGAUUGGAACAGGGAUCUUAGGUCUGCCUCUCUCUCUCUCUCUCUCUCUCUCUCUCUCUCUGUGUGUGUGUGUGUGUGUGUGAAGUUUUUUACAGGUGAAUAAACAAAGUUUGAAAGA-3'- Poly-A tail
- Coding region
DNA
DNA (Gene ID: 284)
angiopoietin 1
strand -
KIAA0003, Ang1, AGPT-1
NCBI CDS gene sequence (1497 bp)
5'-ATGACAGTTTTCCTTTCCTTTGCTTTCCTCGCTGCCATTCTGACTCACATAGGGTGCAGCAATCAGCGCCGAAGTCCAGAAAACAGTGGGAGAAGATATAACCGGATTCAACATGGGCAATGTGCCTACACTTTCATTCTTCCAGAACACGATGGCAACTGTCGTGAGAGTACGACAGACCAGTACAACACAAACGCTCTGCAGAGAGATGCTCCACACGTGGAACCGGATTTCTCTTCCCAGAAACTTCAACATCTGGAACATGTGATGGAAAATTATACTCAGTGGCTGCAAAAACTTGAGAATTACATTGTGGAAAACATGAAGTCGGAGATGGCCCAGATACAGCAGAATGCAGTTCAGAACCACACGGCTACCATGCTGGAGATAGGAACCAGCCTCCTCTCTCAGACTGCAGAGCAGACCAGAAAGCTGACAGATGTTGAGACCCAGGTACTAAATCAAACTTCTCGACTTGAGATACAGCTGCTGGAGAATTCATTATCCACCTACAAGCTAGAGAAGCAACTTCTTCAACAGACAAATGAAATCTTGAAGATCCATGAAAAAAACAGTTTATTAGAACATAAAATCTTAGAAATGGAAGGAAAACACAAGGAAGAGTTGGACACCTTAAAGGAAGAGAAAGAGAACCTTCAAGGCTTGGTTACTCGTCAAACATATATAATCCAGGAGCTGGAAAAGCAATTAAACAGAGCTACCACCAACAACAGTGTCCTTCAGAAGCAGCAACTGGAGCTGATGGACACAGTCCACAACCTTGTCAATCTTTGCACTAAAGAAGGTGTTTTACTAAAGGGAGGAAAAAGAGAGGAAGAGAAACCATTTAGAGACTGTGCAGATGTATATCAAGCTGGTTTTAATAAAAGTGGAATCTACACTATTTATATTAATAATATGCCAGAACCCAAAAAGGTGTTTTGCAATATGGATGTCAATGGGGGAGGTTGGACTGTAATACAACATCGTGAAGATGGAAGTCTAGATTTCCAAAGAGGCTGGAAGGAATATAAAATGGGTTTTGGAAATCCCTCCGGTGAATATTGGCTGGGGAATGAGTTTATTTTTGCCATTACCAGTCAGAGGCAGTACATGCTAAGAATTGAGTTAATGGACTGGGAAGGGAACCGAGCCTATTCACAGTATGACAGATTCCACATAGGAAATGAAAAGCAAAACTATAGGTTGTATTTAAAAGGTCACACTGGGACAGCAGGAAAACAGAGCAGCCTGATCTTACACGGTGCTGATTTCAGCACTAAAGATGCTGATAATGACAACTGTATGTGCAAATGTGCCCTCATGTTAACAGGAGGATGGTGGTTTGATGCTTGTGGCCCCTCCAATCTAAATGGAATGTTCTATACTGCGGGACAAAACCATGGAAAACTGAATGGGATAAAGTGGCACTACTTCAAAGGGCCCAGTTACTCCTTACGTTCCACAACTATGATGATTCGACCTTTAGATTTTTGA-3'
By using this site you agree to our privacy policy.
Please confirm you agree with the privacy policy before using the site.